Evidence map›Paper›PMID 33420335›Full record

ArticleScientific reports2021

False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance.

Jonas M den Heijer, Arnoud Schmitz, Peter Lansbury, Valerie C Cullen, Dana C Hilt, Vincenzo Bonifati, Geert Jan Groeneveld

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2024
    Review
  4. Next-Generation Sequencing Analysis ofFrontiers in genetics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Jonas M den HeijerCentre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands.
Arnoud SchmitzGenomeScan B.V, Leiden, The Netherlands.
Peter LansburyLysosomal Therapeutics Inc, Cambridge, MA, USA.
Valerie C CullenLysosomal Therapeutics Inc, Cambridge, MA, USA.
Dana C HiltLysosomal Therapeutics Inc, Cambridge, MA, USA.
Vincenzo BonifatiDepartment of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Geert Jan GroeneveldCentre for Human Drug Research, Zernikedreef 8, 2333 CL, Leiden, The Netherlands. ggroeneveld@chdr.nl.
Lysosomal Therapeutics (United States) · USLeiden University Medical Center · NLErasmus MC · NLGenomeScan (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A variant in the GBA1 gene is one of the most common genetic risk factors to develop Parkinson's disease (PD). Here the serendipitous finding is reported of a polymerase dependent allelic imbalance when using next generation sequencing, potentially resulting in false-negative results when the allele frequency falls below the variant calling threshold (by default commonly at 30%). The full GBA1 gene was sequenced using next generation sequencing on saliva derived DNA from PD patients. Four polymerase chain reaction conditions were varied in twelve samples, to investigate the effect on allelic imbalance: (1) the primers (n = 4); (2) the polymerase enzymes (n = 2); (3) the primer annealing temperature (T

Indexed as

Allelic ImbalanceExonsGlucosylceramidaseHumansParkinson DiseasePolymerase Chain ReactionSequence Analysis, DNAGBA protein, humanGlucosylceramidase

Identifiers

PMID33420335
PMCPMC7794395
OpenAlexW3120472233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.